Crescent Biopharma, Inc.

NASDAQ:CBIO

Biotechnology

Healthcare
$12.40 -2.69%

-$0.49 today

Market cap
$482.30M
Beta
1.15
P/E (TTM)
-3.3
EPS (TTM)
-$5.33
52W Low $8.72High $27.41

Volume 0.33M

Average 0.28M

Price history

Crescent Biopharma, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-4.62%

Period high

$26.98

Period low

$8.94

Latest

$12.40

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
SC 13GOct 27, 2026Oct 27, 2026
8-KOct 15, 2026Oct 15, 2026
4Sep 18, 2026Sep 18, 2026
4Sep 18, 2026Sep 18, 2026
4Sep 18, 2026Sep 18, 2026
4Sep 18, 2026Sep 18, 2026
4Sep 18, 2026Sep 18, 2026
4Sep 18, 2026Sep 18, 2026
4Sep 18, 2026Sep 18, 2026
S-8Sep 18, 2026Sep 18, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
EFFECTJul 31, 2026Aug 3, 2026
8-KJul 30, 2026Jul 30, 2026

Competitors

Who does Crescent Biopharma, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CBIO's filings, answered from its disclosures.

What is the latest CBIO filing?

The latest filing shown is 8-K dated Nov 12, 2026.

How many recent filings does CBIO have?

Intrinsic Alpha currently shows 20 recent filings for CBIO.